DFTX Q2 2019 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

Q2 2019 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$1,723

Operating Income

-$167,422

Net Income

-$167,422

EPS (Diluted)

$-0.41

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$268,848

Free Cash Flow

-$268,850

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$4M

Total Liabilities

$140,844

Stockholders' Equity

$3M

Cash & Equivalents

$46,965

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,723	-$6,960	+75.2%
Operating Income	-$167,422	-$472,445	+64.6%
Net Income	-$167,422	-$471,489	+64.5%